QUARTO-II Study to Evaluate the Management of Patients Resynchronized With the QuartetTM LV Quadripolar Lead

NCT01733368 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 198

Last updated 2019-02-04

Study results available
· View outcomes & findings →

Summary

Optimization and evolution of the patient will be evaluated over 6 months after the implant.

Conditions

Sponsors & Collaborators

  • Abbott Medical Devices

    lead INDUSTRY

Principal Investigators

  • Javier Alzueta, MD · Hospital Clínico Universitario Virgen de la Victoria

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-11-30
Primary Completion
2015-08-31
Completion
2016-08-31

Countries

  • Spain

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01733368 on ClinicalTrials.gov